13^th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology July 24-25, 2017 Rome, Italy

ConferenceSeries Ltd is a renowned organization that organizes highly notable  international conferences throughout the globe. Currently we are bringing forth “13^th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology” (NanoMed 2017) scheduled to be held during July 24-25, 2017 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Drug delivery.

The main theme of the conference is “Emerging Importance of Nanotechnology to Drive the Pharma Industry”.

NanoMed 2017 is a unique platform to meet fellow key decision makers and experts all-around the Academic Institutions, Healthcare Institutes, Pharmaceutical, Biotech, Biomedical, Formulation scientists and researchers making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies. It's a perfect stage to brainstorm, discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world.

ConferenceSeries Ltd organizes a conference series of 3000+ Global Events with over 1000+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Top Reasons to Attend

• A unique opportunity to discuss issues of importance and relevance to advancing pharmacy practice through continuous professional development.
• The conference is of interest to all those in the Continuing Education/Professional Development experience, including pharmacists, developers, sponsors, faculty, regulators, government, professional associations, pharmaceutical industry, communication companies, and allied health care providers and organizations from around the world.
• Meet with key decision makers in the pharmaceutical industry worldwide and learn about the latest innovations, technologies, trends and developments in pharmaceutical industry.
• Network and gain access to one of the world's fastest growing pharmaceutical markets.
• A momentum is growing world-wide that recognizes the integral role of continuing professional development in Pharmaceutical Industry, and the value of sharing experiences and knowledge in an international, collegial forum.
• The conference facilitates participant access to high quality educational programs, internationally significant research and development, and world-renowned leaders in the Pharmaceutical field.
• This is the only event featuring renowned speakers and delegates and expertise on the topics you care about most!

Target Audience

• Professors, Associate Professors, Asst Professors
• PhD Scholars
• Graduates and Post Graduates
• Directors, CEO’s of Organizations
• Association, Association presidents and professionals
• Noble laureates in Health Care and Medicine
• Bio instruments Professionals
• Research Institutes and members
• Supply Chain companies
• Manufacturing Companies
• Training Institutes
• Business Entrepreneurs

2017 Highlights:

• 300+ Participation (70 Industry: 30 Academia)
• 5+ Keynote Speakers
• 50+ Plenary Speakers
• 20+ Exhibitors
• 14 Innovative Educational Sessions
• 5+ Workshops
• B2B Meetings

Summary:

Nanotechnology will have a broad and fundamental impact on many sectors of the U.S. economy; various technical, marketing and other hurdles need to be overcome before nanotechnology fulfills this promise. These challenges and differences of opinion regarding commercial applications are reflected in the widely diverging estimates of the U.S. and global nanotechnology markets.

According to BCC Research, the global market for nanoparticles in the life sciences is estimated at over $29.6 billion for 2014. This market is forecast to grow to more than $79.8 billion by 2019, to register a healthy compound annual growth rate (CAGR) of 22%. The biggest increase will come in the area of drug delivery systems.

As products complete clinical trials and gain US FDA market approval, the revenues from these products will grow at 23%. Basic biotechnology research revenues will increase due to the quest to find more nanoparticle applications, as more drugs become successfully delivered by these carrier systems. Drug development and formulation will show steady sustained growth at 20.7%. Nanoparticles for use in diagnostic imaging will continue to show healthy growth at 20.1%. This will result from the need to develop more definitive nanoparticle markets for disease diagnosis. To date, drug delivery has been the main near-term opportunity for medical nanotechnology. This market has an estimated value of $15.8 billion for 2014 and is forecast to grow to $44.5 billion by 2019, to register a significant CAGR of 23%. The drug development category, the second fastest-growing opportunity, was projected at nearly $12.6 billion for 2014 and is expected to increase to $32.2 billion by 2019 at a 20.7% CAGR.

Nanotechnology applications are defined comprehensively as the creation and utilization of materials, devices, and systems through the manipulation of matter at scales of less than 100 nanometers. Nanotechnology covers nanomaterials (nanoparticles, nanotubes, nanostructured materials, and nanocomposites), nanotools (nanolithography tools and scanning probe microscopes), and nanodevices (nanosensors and nanoelectronics).

Scope and Importance:

Nanotechnology is the science which deals with the processes that occur at molecular level and of nanolength scale size. The major studies in the nanotechnology include nanosized particles, their function and behavior with respect to other systems. The tremendous capabilities of nanoparticles have changed the perspective and scope of nanotechnology towards development into an adjuvant field for the remaining fields of life sciences. Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the pharmacokinetics of the drug or other related chemical entities in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor signaling and activity. Pharmaceutical nanotechnology is helpful in the field of pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

Why Rome, Italy???

Rome has the status of a global city. Rome ranked in 2014 as the 14^th most visited city in the world, 3^rd most visited in the European Union, and the most popular tourist attraction in Italy. Its historic center is listed by UNESCO as a World Heritage Site. Monuments and museums such as the Vatican Museums and the Colosseum are among the world's most visited tourist destinations with both locations receiving millions of tourists a year. Rome hosted the 1960 Summer Olympics and is the seat of United Nations' Food and Agriculture Organization (FAO).

Rome is a major EU and international financial, cultural and a business centre. With a 2005 GDP of €94.376 billion (US$121.5 billion), the city produces 6.7% of the national GDP (more than any other single city in Italy), and its unemployment rate, lowered from 11.1% to 6.5% between 2001 and 2005, is now one of the lowest rates of all the European Union capital cities. Rome grows +4.4% annually and continues to grow at a higher rate in comparison to any other city in the rest of the country. This means that were Rome a country, it would be the world's 52nd richest country by GDP, near to the size to that of Egypt. Rome also had a 2003 GDP per capita of €29,153 (US$ 37,412), which was second in Italy, (after Milan), and is more than 134.1% of the EU average GDP per capita. Also, Rome hosts the head offices of the vast majority of the major Italian companies and corporations, as well as the headquarters of 3 of the world's 100 largest companies: Enel, Eni, and Telecom Italia.

Scientific Sessions:

• Pharmaceutical Nanotechnology
• Novel Drug Delivery Technology
• Nanomedicine and Drug Delivery
• Nanotechnology for Pediatric Medicine
• Nanotechnology in Preclinical and Clinical Development
• Nanotechnology for Targeted Drug Delivery
• Regulatory Guidance for Pharmaceutical Nanotechnology
• Future Aspects of Pharmaceutical Nanotechnology
• Recent Advances in Nanotechnology
• Major Challenges in Nanotechnology
• Pharmaceutical Companies and Markets
• Business Opportunities in Nanotechnology

Members Associated with Nanotechnology Research:

• Pharmaceutical Nanotechnology Industries
• Food Nanotechnology research institutes
• Nano scale device Manufacturing Companies
• Pharmaceutical Faculty
• Pharmaceutical Nanotechnology Associations and Societies
• Pharmaceutical Researchers
• Pharmaceutical students
• Nanotechnology Scientists
• Nanotech Business Entrepreneurs
• Consultancies offering nanotechnology courses
• Nanotechnology marketing executives

Major Nanotechnology Associations & Societies:

Associations around Rome:

• The British Society for Nanomedicine
• Italian Association for Industrial Research
• NanoItaly Association

Associations & Societies around Italy:

• ISEKI Food Association (IFA)
• Italian Association for Industrial Research
• Italian Center for Nanotechnology
• Nanotechnology Industries Association
• The CIVEN association of Veneto universities
• Veneto Nanotech

Associations & Societies around the Globe:

• New England Nanotechnology Association (NENA)
• Asian Nanoscience and Nanotechnology Association
• International Association of Nanotechnology
• American Society for Testing and Materials (ASTM International).
• Nanoscale Science Research Centers (NSRCs)
• Australian Research Council Nanotechnology Network (ARCNN)
• Global Nanotechnology Network (GNN)
• Materials Research Society
• International Union of Materials Research societies
• Major Nanotechnology Associations around the Europe
• German Association of Nanotechnology
• Brazilian Nanotechnology National Laboratory
• International Council on Nanotechnology (ICON)
• Nano Science and Technology Institute (NSTI)
• Nano Canadian Society
• American Nano Society
• American Society for Nanomedicine
• Society for Personalized Nanomedicine
• Royal Society-NanoTechnology and NanoScience
• International Association of Nanotechnology (IANT)
• American Association for the Advancement of Science
• Congress on Innovation in Drug Delivery (APGI)
• Controlled Release Society (CRS)
• American Academy of Nanomedicine (AANM)
• Nanotechnology and Nanoscience Student Association (NANSA)
• Canadian NanoBusiness Alliance
• European NanoBusiness Association
• International Association of NanoTechnology (IAN)
• British Society for Nanomedicine
• Czech Nanotechnology Industries Association
• Erwin Schrödinger Society for Nanosciences
• European Society for Precision Engineering and Nanotechnology (EUSPEN)
• Korea Nano Technology Research Society
• Nano Science and Technology Consortium (NSTC)
• Nanotechnology Industries Association (NIA)
• Royal Society - Nanotechnology and Nanoscience
• Russian Society of Scanning Probe Microscopy and Nanotechnologies

Statistics:

Major Pharmaceutical Universities:

Universities in Rome:

• Sapienza University of Rome
• University of Rome Tor Vergata
• Roma Tre University

Universities in Italy:

• Magna Græcia University
• Sapienza University of Rome
• University of Bari
• University of Bologna
• University of Cagliari
• University of Camerino
• University of Catania
• University of Chieti-Pescara
• University of Ferrara
• University of Florence
• University of Genoa
• University of Messina
• University of Milan
• University of Modena and Reggio Emilia
• University of Naples Federico II
• University of Padua
• University of Palermo
• University of Parma
• University of Pavia
• University of Perugia
• University of Pisa
• University of Salerno
• University of Sassari
• University of Siena
• University of Trieste
• University of Turin
• University of Urbino

Major Universities around globe:

• University of North Carolina
• University of Minnesota
• University of California
• University of Michigan
• University of Texas
• Ohio State University
• University of Illinois
• University of Kentucky
• Purdue University
• University of Florida
• University of Maryland
• University of Pittsburgh
• University of Southern California
• University of Washington
• University of Wisconsin
• University of Arizona
• University of Iowa
• University of Tennessee Health Science Center
• University of Utah
• Virginia Commonwealth University
• University of Kansas
• University at Buffalo
• University of Colorado
• University of Mississippi
• Auburn University (Harrison)

Statistics:

Italy Statistics:

Major Nanotechnology Companies in Italy:

• Tec Star
• MBN Nanomaterialia
• NANO-CAT
• Scriba Nanotecnologie
• Tethis
• Nanto Protective Coating

Nanotechnology Organisations:

• Istituto Italiano di Tecnologia (IIT)
• CIVEN (Coordinamento Interuniversitario Veneto per le Nanotecnologie)

Universities offering Nanotechnology Education in Italy:

• National Nanotechnology Laboratory
• Veneto Nanotech
• CNR-IFN
• LATEMAR (Laboratorio di Tecnologie Elettrobiochimiche Miniaturizzate per l'Analisi e la Ricerca)
• Polytechnic University of Turin
• University of Milano Bicocca
• University of Modena and Reggio Emilia
• Carbon Nanotechnology Group
• Centre for Nanoscience and Technology (CNST)

Global Market Analysis for Nano medicine:

Global Nano medicine market was valued at $214.2 billion in 2013 and $248.3 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 16.3% from 2014 through 2019 and reach $528 billion by 2019.

Global Market Analysis for Nanotechnology Products:

The global market for nanotechnology products was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019.

Global Market Analysis for Nanotechnology:

The global market for nanotechnology research was valued at nearly $20.1 billion in 2011 and should reach $20.7 billion in 2012. Total sales are expected to reach $48.9 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 18.7%.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the NanoPharma 2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the NanoPharma 2017 organizing committee look forward to meeting you in Rome, Italy.

Fund Allotment to Nanotechnology Research:

Scientific research is a costly endeavor, especially as subjects become more specialized and require expensive equipment, such as a highly detailed scanning tunneling microscope in the case of nanotechnology. Governments around the world are strong supporters of both basic and applied scientific research. In the U.S., dozens of federal agencies, departments, and offices provide grants and contracts to researchers, organizations, universities, and other institutions that increase the body of knowledge in the scientific community. In addition, some states have grant systems for nanotechnology and other scientific research. In the U.S., the National Nanotechnology Initiative (NNI) has coordinated all government nanotechnology funding across 22 government agencies since 2001.

Generally Universities receive funding from many other outside sources for research, including the government and the business sector and sometimes universities may act as source of research. In the nanotechnology research sector in the U.S., most major businesses are engaging in nanotechnology research of some kind whether in electronics or health care or other areas. Market research firms estimate that public and private organizations and governments combined spent $10 billion on nanotechnology research in 2004, with more predicted for 2005. In addition, 2005 was expected to be the first year where corporate investment overtook government funding.

While EU governments are making funding available for nanotechnology research, major pharmaceutical companies are investing very little money or human resources in this field. Nanotech presents many opportunities to pharmaceutical giants, ranging from better delivery of existing drugs to entirely new therapies based on nanomaterial’s, if this trend continues, nanotech will play out in pharmaceuticals just as biotechnology did, with major pharmaceutical companies leaving money on the table and allowing new competitors to take root.

However, given the increasing pressure on the pharmaceutical industry's drug pipeline, the European pharmaceutical industry, for example, increased its spending on research and development from some 11.2 billion euro in 1995 to more than 20 billion euro in 2002. This result in delay in the supply of new medicines then the number of new medicines launched on the market has declined from an average of almost 40 a year in the 1990's to just over 20 since 2000.

According to the report, nanotechnology could help solve the industry's pipeline problems by improving the delivery and efficacy of developmental and marketed drugs, while new nanomaterial’s could develop into novel treatment strategies in the form of biologically active implants. Yet, according to the report's findings, based on interviews with nanotechnology experts from 33 global corporations, 'big pharmaceutical companies on average commit 16 people and less than half of one percent of R&D spending to nanotechnology research.

Most recently, Germany made a 50 million euro fund available for start-ups in the 'bionanotechnology' field as part of the Nanotechnology for Health and Society (NanoforLife) programme. Similarly, in 2004 France increased its funding for nanosciences and nanotechnologies to 70 million a year over three years and in 2003 the UK earmarked 90 million GBP (130 million euro) to its micro and nanotechnology manufacturing initiative.